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The epithelial Ca2 channel transient receptor potential vanilloid 5 (TRPV5) constitutes the apical entry
gate for active Ca2 reabsorption in the kidney. Ca2 influx through TRPV5 induces rapid channel inactiva-
tion, preventing excessive Ca2 influx. This inactivation is mediated by the last30 residues of the carboxy (C)
terminus of the channel. Since the Ca2-sensing protein calmodulin has been implicated in Ca2-dependent
regulation of several TRP channels, the potential role of calmodulin in TRPV5 function was investigated.
High-resolution nuclear magnetic resonance (NMR) spectroscopy revealed a Ca2-dependent interaction
between calmodulin and a C-terminal fragment of TRPV5 (residues 696 to 729) in which one calmodulin binds
two TRPV5 C termini. The TRPV5 residues involved in calmodulin binding were mutated to study the
functional consequence of releasing calmodulin from the C terminus. The point mutants TRPV5-W702A and
TRPV5-R706E, lacking calmodulin binding, displayed a strongly diminished Ca2-dependent inactivation
compared to wild-type TRPV5, as demonstrated by patch clamp analysis. Finally, parathyroid hormone (PTH)
induced protein kinase A (PKA)-dependent phosphorylation of residue T709, which diminished calmodulin
binding to TRPV5 and thereby enhanced channel open probability. The TRPV5-W702A mutant exhibited a
significantly increased channel open probability and was not further stimulated by PTH. Thus, calmodulin
negatively modulates TRPV5 activity, which is reversed by PTH-mediated channel phosphorylation.
TRPV5 belongs to the transient receptor potential (TRP)
superfamily of cation-selective ion channels with comparable
molecular architecture but versatile physiological functions (20).
Based on the homology, TRP channels are classified within six
related subfamilies: classical or canonical (TRPC), melastin-
related (TRPM), polycystins (TRPP), mucolipins (TRPML),
ANKTM1-related (TRPA), and vanilloid receptor-related
(TRPV). Of all TRP channels, TRPV6 holds the highest ho-
mology with TRPV5 (30). Both are highly Ca2 selective and
share biophysical properties clearly distinct from other TRP
channels. Generation of TRPV5 knockout mice demonstrated
the critical role of TRPV5 as gatekeeper of active Ca2 reab-
sorption in the renal handling of Ca2 (13).
TRPV5 contains six putative transmembrane domains and
intracellular amino (N) and C termini. A functional TRPV5
channel exists as a tetramer comprising a central Ca2-selec-
tive pore by the hydrophobic region between transmembrane
domains 5 and 6 (30). Electrophysiological studies of human
embryonic kidney 293 (HEK293) cells heterologously express-
ing TRPV5 demonstrated that the channel is constitutively
active at physiological membrane potentials as no stimulus or
ligand was required for TRPV5-mediated Ca2 entry (12, 32).
The Ca2 current amplitude of TRPV5 is highly dependent on
the electrochemical gradient. Increasing extracellular Ca2
levels or the negative membrane potential amplified the Ca2
current, resulting in an elevated intracellular Ca2 concentra-
tion ([Ca2]i) (32). In the absence of Ca
2 ions, TRPV5 is also
permeable to monovalent cations (32). The residue D542 of
TRPV5 is essential for Ca2 selectivity and permeability (22,
24). Alanine substitution at this position yielded a mutant
channel (D542A) in which Ca2 permeation was blocked while
it was still permeable for Na (24).
To prevent excessive Ca2 influx, TRPV5 harbors a Ca2-
dependent feedback mechanism allowing rapid inactivation of
the channel. The rate of TRPV5 inactivation correlated di-
rectly with the Ca2 current amplitude, indicating that the
influx of Ca2 inhibits channel activity (23, 32, 33). Moreover,
this inhibition was absent when Na was used as the charge
carrier (32). Besides the influx of Ca2 through the pore, the
channel was also shown to be sensitive to resting intracellular
Ca2 concentrations (22). Increasing levels of intracellular
Ca2 lowered TRPV5-mediated Na currents in a concentra-
tion-dependent manner (22). Convincingly, these effects were
also observed for the Ca2-impermeable D542A mutant (22).
Therefore, it was suggested that Ca2 entry through TRPV5
elevates the local Ca2 concentration in a microdomain near
the channel pore, resulting in channel inactivation (22).
In 2003, Nilius et al. demonstrated that the C terminus of
TRPV5 plays a role in Ca2-induced inactivation (25). Re-
moval of the last 30 amino acids rendered the channel less
sensitive for Ca2 (25). Until now, the molecular mechanism
for Ca2-dependent inactivation of TRPV5 has remained elu-
sive. For TRPV6, a close homologue of TRPV5, it was shown
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that Ca2-dependent inactivation is regulated by the Ca2-
sensing protein calmodulin via binding to the channel’s C ter-
minus (residues 691 to 711) (16, 21). Calmodulin inhibited
TRPV6 activity, which was counteracted by protein kinase
C-mediated phosphorylation of the T702 residue (21). Al-
though calmodulin did bind to the TRPV5 C terminus (16), no
role for this binding in the channel regulation was identified.
Interestingly, calmodulin also binds and regulates many other
TRP channels although the precise role of calmodulin in chan-
nel functioning remains to be identified (37).
The aim of the present study was to unravel the molecular
mechanism underlying Ca2-dependent TRPV5 inactivation.
Therefore, we combined functional methods such as fura-2
measurements and patch clamp analysis with nuclear magnetic
resonance (NMR) spectroscopy, a technique providing infor-
mation about molecular interactions at the atomic level.
MATERIALS AND METHODS
Protein expression and purification. For production of the uniformly 13C-
and/or 15N-labeled C-terminal calmodulin binding domain of human TRPV5
(residues 696 to 729 [hTRPV5696–729]), a recombinant approach was used. A
synthetic gene optimized for Escherichia coli was purchased from Mr.Gene
GmbH (Regensburg, Germany). The coding sequence was cloned into a pGEV2
expression vector (14). The fusion protein with an N-terminal GB1 tag and
C-terminal His6 tag was overexpressed in M9 minimal medium containing 4
g/liter [13C6]glucose and/or 1 g/liter [15N]ammonium chloride (Buchem BV,
Apeldoorn, Netherlands) as the sole source of carbon and/or nitrogen, respec-
tively. The GB1-hTRPV5696–729-His6 fusion protein was purified by affinity chro-
matography using IgG-Sepharose (GE Healthcare) according to the manufac-
turer’s instructions. The final purification step was done via ion-exchange
chromatography using a MonoQ 5/50 column (GE Healthcare). The GB1 tag
was cut by thrombin (Sigma-Aldrich) according to the manufacturer’s instruc-
tions. hTRPV5696–729 with a C-terminal His6 tag was further purified by IgG-
Sepharose.
Nonlabeled and uniformly 15N-labeled recombinant Xenopus laevis calmodulin
(identical to mammalian) was expressed in E. coli AR58 cells carrying the
pTNcoI2 plasmid (kind gift of C. Klee, NIH, Bethesda, MD). Expression was
induced by a temperature shift from 30°C to 42°C, and 3 to 4 h after induction
cells were harvested and lysed. Calmodulin was purified by weak anion exchange
(DEAE; GE Life Sciences) and affinity chromatography (Phenylsepharose; GE
Life Sciences). Purified protein was dialyzed against a 1/100 mixture of 50 mM
KCl, 10 mM CaCl2, and 20 mM Tris (pH 7.0)-HCl buffer, freeze-dried, and
stored at 20°C.
Peptide synthesis. Peptide hTRPV5696–729 (GSHRGWEILRQNTLGHLNLG
LNLSEGDGEEVYHF) corresponding to residues 696 to 729 of hTRPV5 (with
an N-terminal Ser mutated to Gly) was purchased from Peptides and Elephants
GmbH (Potsdam, Germany). It was purified by high-performance liquid chro-
matography ([HPLC] 95% purity) and analyzed by mass spectrometry.
NMR sample preparation. For the NMR titration of 15N-labeled calmodulin
by synthetic peptide hTRPV5696–729, a series of samples with a protein-ligand
molar ratio ranging from 1:0 to 1:4 was prepared. Due to solubility problems, the
peptide was first dissolved in 20 mM Tris (pH 8.5)-HCl, mixed with calmodulin
in an appropriate ratio, and then dialyzed against a 1/100 mixture of 50 mM KCl,
10 mM CaCl2, and 20 mM Tris (pH 7.0)-HCl. After lyophilization the samples
were reconstituted in 50 mM KCl, 10 mM CaCl2, and 20 mM Tris (pH 7.0)-HCl.
D2O and NaN3 (both from Sigma-Aldrich) were added to the NMR samples to
final concentrations of 5 to 7% (vol/vol) and 0.01% (vol/vol), respectively. The
concentration of calmodulin in the samples was 200 M. Due to already
mentioned solubility problems, 13C- and/or 15N-labeled hTRPV5696–729-His6 was
dissolved in 10 mM CaCl2–10 mM CH3COONH4 (pH 5.0)–NaOH. For titration,
the nonlabeled calmodulin was dissolved in the same buffer. The concentration
of 13C,15N-labeled hTRPV5696–729-His6 was 150 M.
NMR spectroscopy. Spectra were recorded at 298 K on a Varian Inova 600 or
800 MHz equipped with a standard triple resonance probe and a cold probe,
respectively. For titration of calmodulin with peptide (and vice versa), two-
dimensional (2D) 15N-1H-heteronuclear single-quantum coherence (HSQC)
spectra were recorded. For sequential assignment of hTRPV5696–729, three-
dimensional (3D) HNCACB and CBCA(CO)NH experiments were performed.
All spectra were processed by NMRpipe suite (7) and analyzed by the program
CcpNmr Analysis (34).
Construction of mammalian expression vectors. The human parathyroid hor-
mone (hPTH) receptor cDNA was cloned in the pCB7 vector behind a phos-
phoglycerate kinase (PGK) promoter using HinDIII and BamHI. The bicistronic
expression vector pCINeo/IRES-eGFP (where IRES is internal ribosome entry
site) was implemented for coexpression of rabbit TRPV5 containing an N-ter-
minally fused hemagglutinin (HA) tag and enhanced green fluorescent protein
(eGFP). The rabbit TRPV5 C terminus (amino acids 617 to 730) was cloned into
the pGEX 6p-2 vector. Mutations in TRPV5 and glutathione S transferase
(GST)-TRPV5 were introduced using site-directed mutagenesis (Stratagene, La
Jolla, CA), according to the manufacturer’s protocol, after which all plasmids
were sequence verified.
Cell culture and transfection. HEK293 cells were grown in Dulbecco’s mod-
ified Eagle’s medium (DMEM; Bio Whittaker Europe, Vervier, Belgium) con-
taining 10% (vol/vol) fetal calf serum (PAA, Linz, Austria), 2 mM L-glutamine,
and 10 l/ml nonessential amino acids at 37°C in a humidity-controlled incubator
with 5% (vol/vol) CO2. Cells were transiently transfected with the appropriate
plasmids using polyethyleneimine (PEI; Brunswig/PolySciences Inc.) with a
DNA-PEI ratio of 6:1 for biochemical or live-cell imaging experiments. For patch
clamp experiments, cells were transiently transfected with the appropriate plas-
mids using Lipofectamine 2000 (Invitrogen, Breda, Netherlands). For all exper-
iments, transfected cells were used after 24 h.
Calmodulin precipitation assay. Calmodulin-coupled Sepharose 4B beads
(GE Healthcare Bio-Sciences AB, Uppsala, Sweden) were incubated for 60 min
at room temperature (RT) with bacterial lysate containing GST, GST fused to
the wild-type TRPV5 (GST-TRPV5-WT), and point mutants, as previously de-
scribed (31). After extensive washing using Tris-buffered saline (pH 7.4) con-
taining 2% (vol/vol) Triton X-100 and protease inhibitors, proteins were eluted
from beads with SDS-PAGE loading buffer, separated on an SDS-polyacryl-
amide gel, and analyzed by immunoblotting using an anti-GST antibody (1:2,000;
Sigma-Aldrich, St. Louis, MO).
Intracellular Ca2 measurements using fura-2-AM. HEK293 cells were
seeded on fibronectin-coated coverslips (diameter, 25 mm) and transfected with
the appropriate pCINeo/IRES-eGFP vector. After 24 h, cells were loaded with
3 M fura-2-acetoxymethyl ester (fura-2-AM; Molecular Probes) and 0.01%
(vol/vol) Pluronic F-129 (Molecular Probes) in DMEM at 37°C for 20 min. After
cells were loaded, they were washed twice with phosphate-buffered saline (PBS)
and allowed to equilibrate at 37°C for another 10 min in 132.0 mM NaCl, 4.2 mM
KCl, 1.4 mM CaCl2, 1.0 mM MgCl2, 5.5 mM D-glucose, and 10 mM HEPES (pH
7.4)-Tris. For Ca2-free conditions, a similar buffer composition was used in
which Ca2 was replaced with 2 mM EGTA.
Details of microscopy procedures and quantitative image analysis have been
described previously (6). In short, fura-2-loaded cells were placed on an inverted
microscope using an incubation chamber. Changes in extracellular Ca2 were
facilitated using a perfusion system, and the resulting changes in Ca2 were
monitored with fura-2 excited at 340 and 380 nm. Only those cells responding to
a Ca2-EGTA-Ca2 treatment were included. All measurements were per-
formed at room temperature. Full-length human PTH (Bachem AG, Bubendorf,
Switzerland) was added at 75 s after the start of recording.
Electrophysiology. Patch clamp experiments were performed as described
previously (24, 32) in the tight-seal whole-cell configuration at room temperature
using an EPC-10 patch clamp amplifier controlled by the Pulse software (HEKA
Elektronik, Lambrecht, Germany). Cells were kept in nominal divalent-free
solution to prevent Ca2 overload. For whole-cell patch clamp, patch pipettes
had a resistance between 2 and 4 M after they were filled with the standard
intracellular solution (5). Cells were held at 20 mV, and voltage ramps of 450
ms ranging from 100 to 100 mV were applied to measure current/voltage
(I/V) relations. Ca2 currents were measured for 3 s at 100 mV stepping from
a holding potential of 70 mV. Cell capacitance and access resistance were
continuously monitored using the automatic capacitance compensation of the
Pulse software. Current densities were obtained by normalizing the current
amplitude to the cell membrane capacitance. Whole-cell patch clamp data were
analyzed using Igor Pro software (WaveMetrics, Lake Oswego, OR). For cell-
attached single-channel recordings, pipette resistance was between 7 and 10 M.
Cells were perfused with the following solution: 140 mM KCl, 5 mM EDTA, 5
mM EGTA, 1 mM MgCl2, 10 mM glucose, and 10 mM HEPES (pH 7.2)-KOH.
The pipette contained 140 mM NaCl, 10 mM EGTA, and 10 mM HEPES (pH
7.2)-NaOH. The sampling rate was 10 kHz; currents were filtered at 1 kHz. The
analysis of single-channel data was performed using TAC software (Bruxton,
Seattle, WA). Channel conductance was measured using a step protocol ranging
from 100 mV to 80 mV in 20-mV increments, and every step lasted for 2 s.
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Statistical analysis. Numerical results were visualized using Origin Pro, ver-
sion 7.5 (OriginLab Corp., Northampton, MA), and are presented as the mean
standard error of the mean (SEM). Statistical differences were determined using
a one-way analysis of variance (ANOVA), followed by a Newman-Keuls multiple
comparison test. P values below 0.05 were considered significant.
RESULTS
The C terminus of TRPV5 binds calmodulin in a Ca2-
dependent manner. To study the role of the last 30 amino acids
of TRPV5 in relation to the Ca2-induced channel inactivation
(9), we investigated this C-terminal part of TRPV5 for poten-
tial calmodulin binding. Native polyacrylamide gel electro-
phoresis was used to study in vitro interactions of calmodulin
with the synthetic peptide hTRPV5696–729. Lanes 1 and 2 of
Fig. 1 depict calmodulin and hTRPV5696–729 peptide, re-
spectively, in the presence of Ca2. Combining calmodulin
and hTRPV5696–729 at a 1:0.5 molar ratio in the presence of
Ca2 (lane 3) eliminated the band previously visible at the
height of the free peptide. This suggests that the TRPV5
peptide is bound by calmodulin, and this calmodulin-
hTRPV5696–729 complex appeared as a band above free cal-
modulin. Upon increase of the peptide concentration (Fig. 1,
lanes 4 to 6), the band of free calmodulin disappeared, and the
formation of a second complex was detected. In the presence
of EGTA (lanes 7 to 9), calmodulin migrated to a lower
height within the gel, and complex formation of calmodulin-
hTRPV5696–729 was not detected.
Specific binding of hTRPV5696–729 to calmodulin is confirmed
by NMR spectroscopy. Chemical shift perturbation (CSP) ex-
periments are widely used to define binding sites in biomolec-
ular complexes. In particular, 2D heteronuclear single quan-
tum coherence (HSQC) experiments are often used in protein
NMR spectroscopy to study in vitro interactions (3). The re-
sulting two-dimensional spectrum contains chemical shifts of
1H on one axis and chemical shifts of a directly attached het-
eronucleus (i.e., 15N for 15N-1H-HSQC) on the second axis,
and each peak corresponds to a unique amide proton. For
example, in an HSQC spectrum of 15N-labeled protein, when
an interaction of the protein under consideration with another
molecule occurs, the peaks corresponding to specific amino
acids involved in this interaction will change their position in
the spectrum (chemical shift perturbation) and thus will allow
the determination of the binding site. It should be noted that
CSPs not only may arise from direct interaction with a binding
partner but also may be caused by allosteric effects and struc-
tural changes in the protein upon binding. Thus, the residues
with the largest CSPs are suggested to be located at only
critical spots in the binding interface. 15N-1H-HSQC spectra of
free 15N-labeled hTRPV5696–729 and hTRPV5696–729 in the
presence of calmodulin are shown in Fig. 2A.
Sequential assignment (defining which peak corresponds to
which amino acid) was performed using 3D HNCACB and
CBCA(CO)NH spectra. For the free hTRPV5696–729 peptide,
it was possible to unambiguously assign HN, N, H, C, and
C	 for 80% of the residues (deposited in the Biological
Magnetic Resonance Bank [BMRB], entry 17472). Free pep-
tides of 35 amino acids are often unstructured, as demon-
strated by the narrow dispersion of the hTRPV5696–729 back-
bone amide resonances: most of the peaks are located in the
region of the spectrum characteristic for random coil proteins
(1H chemical shift of 7.6 to 8.2 ppm). Likewise, secondary
structure prediction based on chemical shifts of C, C	, and
H confirmed the absence of distinct structured elements in
free hTRPV5696–729 (data not shown). Addition of nonlabeled
calmodulin to the 15N-labeled free peptide leads to the
changes in 15N-1H-HSQC spectrum, indicating a binding event
(Fig. 2A). A visible increase in spectral dispersion of amide
resonances upon addition of calmodulin (red spectrum) indi-
cated conformational changes in the peptide. Peaks unambig-
uously assigned to the residues of the putative calmodulin
binding site (R699, W701, L704, R705, T708, and L709) were
shifted in the 15N-1H-HSQC spectrum of hTRPV5696–729 in
the presence of calmodulin, which demonstrated their direct
role in the binding. Convincingly, the side chain of W701 also
interacted with calmodulin since a very large 1H chemical shift
difference (0.6 ppm) was observed for the amino group of the
W701 indol ring between bound and nonbound forms. Simi-
larly, the peaks corresponding to Nε of R699 and R705 were
almost absent in the free peptide but were clearly visible and
shifted in the presence of calmodulin (1H chemical shift dif-
ference of up to 0.25 ppm; 15N chemical shift difference of 2
ppm). This fact strongly suggested that the guanidinium groups
of R699 and R705 are also involved in the interaction.
Stoichiometry of binding: one calmodulin per two
hTRPV5696–729 peptides. Titration of 15N-labeled calmodulin
by nonlabeled synthetic peptide hTRPV5696–729 reflected
the changes in calmodulin upon peptide binding. Three 15N-
1H-HSQC spectra of the complexes with calmodulin-
hTRPV5696–729 at molar ratios of 1:0 (black), 1:1 (red), and
1:2 (blue) were recorded and are displayed superimposed in
Fig. 2B. By partial assignment of calmodulin (for well-re-
solved resonances) using previously published results (2), it
was determined that the resonances belonging to the resi-
dues of both the N and C domains of calmodulin (residues
1 to 79 and 81 to 148, respectively) were significantly shifted
FIG. 1. Calmodulin binding to the TRPV5 C terminus. A native
polyacrylamide gel, demonstrating interactions between calmodulin
(CaM) and hTRPV5696–729, is shown. Lanes 1 and 7 contain calmod-
ulin in the presence of Ca2 and EGTA, respectively; lanes 2 and 8
contain hTRPV5696–729 in the presence of Ca2 and EGTA, respec-
tively. The gel demonstrates that in the presence of calcium, calmod-
ulin is forming complexes with hTRPV5696–729 (lanes 3 to 6 contain
calmodulin and hTRPV5696–729 at different ratios in the presence of
Ca2). In the presence of EGTA, no interactions are detected. It
should be noted that the proteins in the absence of SDS separate on
the basis of their charge-to-mass ratios. Proteins with higher molecular
weight may, in fact, run faster than those with the lower molecular
weight.
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in the presence of hTRPV5696–729. Remarkably, in the 15N-
1H-HSQC spectra at 1:1 molar ratio (Fig. 2B, red), several
residues display two peaks, e.g., A102, K115, and L116. One
peak is related to the free Ca2/calmodulin as it is situated very
close to or directly at the position of the free Ca2/calmodulin;
the other peak corresponds to the peptide-bound calmodulin.
Upon increasing hTRPV5696–729 concentration to a calmodu-
lin/hTRPV5696–729 molar ratio of 1:2 (Fig. 2B, blue spectrum),
all double peaks collapsed into single peaks, and most of these
did not coincide with the bound form at a 1:1 molar ratio,
which implied the presence of a second binding event. Upon
further addition of hTRPV5696–729, only minor changes were
detected that included shifting of the equilibrium toward a 1:2
complex and sharpening of the resonances (data not shown).
Mutation of the TRPV5 C terminus reduces calmodulin
binding. To investigate the role of calmodulin in channel func-
tion, the residues suggested by the NMR spectroscopy to be
crucial for calmodulin binding were mutated. First, the binding
to calmodulin was assessed. Calmodulin immobilized on
Sepharose beads was implemented to precipitate the glutathione
S-transferase (GST)-tagged TRPV5 C terminus (residues 617
to 730). The mutation analysis and subsequent functional stud-
ies were performed with the rabbit isoform of TRPV5 as this
isoform is generally used by our laboratory to study TRPV5
function. The rabbit and human C termini are highly conserved
(Fig. 3A). First, GST-TRPV5 precipitation was studied in the
presence of EGTA or Ca2 and compared to the results with
GST alone. The calmodulin beads precipitated GST-TRPV5 in
the presence of Ca2 while both GST alone and TRPV5 in the
absence of Ca2 (EGTA) were not precipitated by calmodulin
(Fig. 3B and C). Second, the positively charged residues with
the largest CSPs were replaced by negatively charged residues,
resulting in the point mutants TRPV5-H699D, -R700E,
-R706E, and -R707E. Substitution of the positive charges sig-
nificantly reduced TRPV5 precipitation by calmodulin (Fig.
3D and E). Mutation of residue R690, which is outside the
proposed calmodulin binding region, did not affect TRPV5
binding to calmodulin (Fig. 3D and E). Third, the bulky hy-
drophobic residues with large CSPs were replaced by the small
hydrophobic residue alanine. These mutants, W702A, L705A,
and L710A, exhibited a significantly reduced precipitation by
calmodulin compared to precipitation of wild-type TRPV5
(TRPV5-WT) protein (Fig. 3F and G).
Calmodulin binding determines TRPV5 activity. Next, the
effect of the various point mutations on TRPV5 function was
studied. Therefore, the point mutations described above were
introduced in the full-length TRPV5 protein, which was sub-
sequently expressed in HEK293 cells. The [Ca2]i was assessed
by fura-2 analysis as a measurement for TRPV5 activity (6).
Figure 4A and B show typical fura-2 traces of the various
mutated TRPV5 proteins over time. Statistical analysis of
[Ca2]i at time (t) zero (0 min; basal conditions) demonstrated
that all point mutations presumed to be located within the
calmodulin binding domain caused an elevation of [Ca2]i
compared to the WT channel level (Fig. 4C). The W702A and
R706E mutants, displaying virtually complete loss of calmod-
ulin binding, exhibited the highest [Ca2]i of all mutants (Fig.
4C). The R690E mutation, which falls outside the calmodulin
binding domain and, therefore, had no effect on calmodulin
interaction, did not affect basal [Ca2]i (Fig. 4C).
To investigate whether removal of calmodulin binding from
TRPV5 alters the Ca2 sensitivity of the channel, the whole-
cell patch clamp technique was used. The Ca2 current gen-
erated by TRPV5-WT was evaluated by the application of a
FIG. 2. In vitro binding of hTRPV5696–729 to calmodulin. (A) 15N-1H-HSQC spectra of hTRPV5696–729 in the absence of calmodulin (black) and
in the presence of 4-fold excess of calmodulin (red). Each peak corresponds to a unique proton attached to a 15N nucleus. Amino acid residues
are marked for which assignment is unambiguous. Nε, nitrogen atom of the side chain amide group R, W, and Q/N. (B) 15N-1H-HSQC spectra
of calmodulin at various concentrations of the synthetic peptide hTRPV5696–729. Calmodulin-peptide molar ratios are represented as follows: black,
1:0; red, 1:1 complex; blue, 1:2 complex.
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hyperpolarizing voltage step to 100 mV from a holding po-
tential of 70 mV. This elicited a strong inward rectification,
followed by rapid Ca2-dependent inactivation, which is char-
acteristic for the TRPV5 channel (Fig. 5A) (32). The mutant
channels TRPV5-W702A and TRPV5-R706E exhibited signif-
icantly slower Ca2-dependent channel inactivation than
TRPV5-WT (Fig. 5A and B). Na current measurements in
nominally divalent-free (DVF) solution (20 M EDTA) dem-
onstrated similar current/voltage profiles and current densities
for both mutants and TRPV5-WT (Fig. 5C and D).
PTH-mediated TRPV5 stimulation is due to the release of
calmodulin. PTH triggers a cyclic AMP (cAMP) pathway that
induces protein kinase A (PKA) activation and subsequent
phosphorylation of the T709 residue of TRPV5 resulting in
channel stimulation (5). As residue T709 is located within the
calmodulin binding site, we hypothesized that phosphorylation
of T709 might prevent calmodulin binding, resulting in in-
creased TRPV5 activity. Therefore, the point mutation mim-
icking the phosphorylated state of TRPV5 (T709D) was intro-
duced in GST-TRPV5 to study the effect on calmodulin
binding. The calmodulin-Sepharose beads precipitated less of
the T709D mutant than TRPV5-WT, whereas precipitation of
the constitutively nonphosphorylated mutant T709A was sim-
ilar to that of the WT (Fig. 6A and B). Next, the role of
calmodulin in TRPV5 stimulation by PTH was studied in
FIG. 3. Assay of GST-TRPV5 binding to calmodulin. (A) Se-
quence alignment of calmodulin binding domains in the last part of the
TRPV5 C terminus for rabbit (rb) and human species. Note the dif-
ference in the numbering of the amino acid positions. The dots indi-
cate the residues involved in the binding of calmodulin, as identified by
NMR spectroscopy. (B) Typical blot of precipitation of GST and
GST-TRPV5 (GST-V5) in the presence of 1 mM Ca2 or 5 mM
EGTA (only TRPV5-WT). Input, total bacterial cell lysate contain-
ing TRPV5; CaM-beads, TRPV5 precipitation by calmodulin beads.
(C) Quantification of TRPV5-Ca2 (n 
 4), TRPV5-EGTA (n 
 3),
and GST-Ca2 (n
 4) precipitation. The asterisk denotes a significant
difference (P  0.05) from TRPV5-Ca2. (D and E) Representative
blot and quantification of TRPV5-WT, -R690E, -H699D, -R700E,
-R706E, and -R707E in the presence of 1 mM Ca2 (all conditions,
n 
 3). (F and G) Representative blot and quantification of TRPV5-
WT, -W702A, -L705A, and -L710A (all conditions, n 
 4). *, P  0.05
versus TRPV5-WT.
FIG. 4. Fura-2 analysis of TRPV5-WT and various point mutants.
(A and B) Representative fura-2 traces in arbitrary units (a.u.) of
HEK293 cells transiently transfected with TRPV5-WT and the differ-
ent point mutants. At t 
 1.5 min the extracellular Ca2 solution (1.4
mM) was replaced by an EGTA solution (2 mM). At t 
 4 min the
EGTA solution was again replaced for Ca2 (1.4 mM). (C) Aver-
aged fura-2 levels of TRPV5-WT (n 
 36) and TRPV5 mutants
R690E (n 
 25), H699D (n 
 25), R700E (n 
 29), W702A (n 

26), L705A (n 
 25), R706E (n 
 25), R707E (n 
 46), and L710A
(n 
 40) at t 
 0. *, P  0.05 versus TRPV5-WT. Data from at least
three independent experiments are shown.
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living cells. To this end, we coexpressed the PTH receptor
and TRPV5-WT or the TRPV5-W702A mutant, which has a
disrupted calmodulin binding site, in HEK293 cells and as-
sessed TRPV5 function by fura-2 analysis. PTH stimulation
increased [Ca2]i of TRPV5-WT (Fig. 6C and D). The [Ca
2]i
in HEK293 cells expressing TRPV5-W702A or the negative
control TRPV5-T709A did not change upon PTH stimulation
(Fig. 6C and D), indicating that PTH-mediated phosphoryla-
tion of T709 results in loss of calmodulin binding and, there-
fore, an increase in intracellular Ca2-levels.
TRPV5-W702A displays an increased channel-open proba-
bility and is not sensitive to PTH stimulation. To study the
interplay between PTH stimulation and calmodulin binding to
the TRPV5 C terminus at a single-channel level, cell-attached
patch clamp analysis was employed. Using HEK293 cells tran-
siently expressing TRPV5-WT or TRPV5-W702A, the patch
pipette was attached to the cell without disrupting the mem-
brane, and TRPV5 channel current was recorded using Na as
a charge carrier. Virtually no channel activity was detected at
positive membrane potentials for both TRPV5-WT (Fig. 7A)
and TRPV5-W702A (Fig. 7B). A voltage step protocol from
100 to 80 mV established a current/voltage (I/V) relationship
revealing an average single-channel conductance of 64  7 pS
(n 
 4) for TRPV5-WT and 69  5 pS (n 
 3) for TRPV5-
W702A (Fig. 7C). After a stable recording of TRPV5 channel
current at 80 mV was obtained, PTH was added to the bath
solution. TRPV5 activity is illustrated by averaged data of
channel-open probability (NPo, where N is the number of
channels and Po is open probability of the channel) of 10-s
intervals of multiple recordings. The average NPo at basal condi-
tions (min 0 to 1) of HEK293 cells expressing TRPV5-WT was
significantly smaller than the NPo of TRPV5-W702A (Fig. 7D).
PTH significantly increased the NPo of TRPV5-WT, while the
NPo of TRPV5-W702A was not affected by PTH treatment
(Fig. 7D). To visualize the kinetics of channel activity upon
PTH stimulation, the averaged NPo levels of TRPV5-WT and
-W702A are depicted in 10-s intervals in Fig. 7E and F, re-
spectively. Maximal TRPV5 open probability is reached 1 min
after PTH stimulation.
DISCUSSION
This study demonstrates the pivotal role of calmodulin in
Ca2-dependent TRPV5 inactivation and the modulation of
this mechanism by PTH. This conclusion is based on the fol-
lowing findings: (i) a calmodulin binding site is present in the
last part of the TRPV5 C terminus; (ii) Ca2-dependent in-
teraction with this part of the C terminus occurs in a mode
enabling one molecule of calmodulin to bind two TRPV5 C
termini; (iii) loss of calmodulin binding enhances TRPV5-
mediated Ca2 influx due to decreased Ca2-dependent inac-
tivation; and (iv) PTH stimulation diminishes calmodulin bind-
ing to the C terminus, leading to an elevation of TRPV5
single-channel activity.
Using NMR spectroscopy, we demonstrated that the C-ter-
minal part of TRPV5 contains a calmodulin binding motif,
which allows two C-terminal peptides to bind one molecule
of calmodulin in a Ca2-dependent manner. The following
FIG. 5. TRPV5-W702A and TRPV5-R706E exhibit diminished
Ca2-induced inactivation. (A) Averaged traces of inward Ca2 cur-
rents measured with 10 mM extracellular Ca2 during a 3-s step to
100 mV from a holding potential of 70 mV in HEK293 cells
expressing either TRPV5-WT (dashed line), TRPV5-W702A (dot-
ted line), or TRPV5-R706E (solid line). (B) Average t1 (time after
which channel activity is inhibited by 50%) values of TRPV5-WT
(n 
 13), TRPV5-W702A (n 
 10), and TRPV5-R706E (n 
 8)
depicted in black bars analyzed via mono-exponential fitting. *, P 
0.05 versus TRPV5-WT. (C) I/V profiles of TRPV5-WT (dashed line),
TRPV5-W702A (dotted line), or TRPV5-R706E (solid line). Cells
were held at20 mV, and voltage ramps of 450 ms ranging from100
to 100 mV were applied to measure I/V relations. (D) Average Na
current density at 80 mV of TRPV5-WT (n 
 13), TRPV5-W702A
(n 
 10), and TRPV5-R706E (n 
 8).
FIG. 6. Role of calmodulin in PTH stimulation of TRPV5. (A and
B) Representative blot and quantification of GST-TRPV5 precipita-
tion using calmodulin beads. (C) Fura-2 ratio in arbitrary units (a.u.)
of HEK293 cells expressing TRPV5-WT (n 
 52), -T709A (n 
 51),
and -W702A (n 
 36) upon PTH stimulation (10 nM) at t 
 75 s.
(D) Statistical analysis of basal fura-2 ratio at t 
 0 (control [CTR])
and after PTH stimulation at t 
 3 min. *, P  0.05 versus CTR. Data
from at least three independent experiments are shown. CaM, beads.
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TRPV5 residues were suggested to be critical for this interac-
tion: R699, W702, L705, R706, T709, and L710 (numeration
for rabbit TRPV5). Stoichiometries different from 1:1 have
previously been reported for calmodulin-protein interactions.
For aquaporin-0 (AQP0), it was also shown that one calmod-
ulin binds two C-terminal peptides, as well as two intact AQP0
molecules (28). The proposed structural model suggests that in
the presence of Ca2, calmodulin binds the C termini from two
neighboring AQP0 monomers, locking these domains in an
orientation that seemingly blocks the pores of two AQP0
monomers within the tetramer. Another example originates
from the crystal structure of cardiac L-type calcium channels
(9). Here, calmodulin binding to the C-terminal regulatory
domain results in two different complexes of calmodulin, one
in a standard 1:1 binding mode and one in an extended con-
formation bridging two parts of the C termini together. Since
TRPV5 is a tetramer in its functional state, calmodulin might
bridge the C termini of the two monomers in a similar fashion.
However, to decipher the gating mechanism by which Ca2-
bound calmodulin modulates TRPV5 inactivation, more struc-
tural data are required.
Calmodulin plays an essential role in numerous Ca2-de-
pendent processes. It is present in all eukaryotic cells and is
highly conserved (100% in animals) (1). To further study the
role of calmodulin in the Ca2-dependent inactivation of
TRPV5, the C-terminal residues of the channel critical for
interaction with calmodulin (as suggested by NMR spectros-
copy) were mutated. Residues essential for calmodulin binding
are also known to have positive and bulky hydrophobic side
chains (15, 36). Fura-2 analysis of these mutants demonstrated
that loss of calmodulin binding elevated TRPV5-mediated
Ca2 influx, leading to an increased [Ca2]i. TRPV5-W702A
and -R706E mutants displayed the highest intracellular Ca2
levels, which was in line with the nearly complete loss of cal-
modulin binding of these mutants. Next, patch clamp analysis
was used in order to identify the molecular mechanism under-
lying TRPV5 activation upon release of calmodulin. Whole-
cell Na currents of mutants W702A and R706E were not
different from those of TRPV5-WT, suggesting that WT and
mutant channels have similar plasma membrane expression
levels. Both the TRPV5-W702A and -R706E mutant exhibited
a decreased peak Ca2 current and a reduced Ca2-dependent
inactivation in comparison to TRPV5-WT. A similar phenom-
enon was recently described for the helix-breaking mutation
M490P, which almost completely abolished TRPV5 inactiva-
tion upon influx of 10 mM Ca2 (18). This mutant displayed
whole-cell Na currents similar to those of TRPV5-WT, and
the peak Ca2 current was reduced, similar to results with the
TRPV5 mutants W702A and R706E. It remains to be con-
firmed whether the mutation M490P in the channel pore and
C-terminal mutations induce the same effects on TRPV5 chan-
nel function. It would therefore be interesting to study the
potential interaction of the TRPV5 C terminus with the chan-
nel pore.
Finally, we demonstrated that loss of calmodulin binding
results in an elevation of the TRPV5 open probability. This
indicates that calmodulin in a Ca2-dependent manner re-
duces the time that the TRPV5 channel spends in an open
FIG. 7. PTH stimulates single-channel activity of TRPV5-WT but not V5-W702A. (A and B) Cell-attached single-channel recordings were
made from HEK293 cells expressing TRPV5-WT or TRPV5-W702A. Channel activity was elicited by step potentials varying from 100 to 80 mV
for TRPV5-WT (A) and TRPV5-W702A (B). (C) Amplitude histograms were constructed from regions of the single-channel recordings and were
fitted by three Gaussian functions corresponding to closed, one open, or two open levels. The averaged calculated slope conductance was 64 
7 pS for TRPV5-WT (n 
 4) and 69  5 pS for TRPV5-W702A (n 
 3). (D) The average NPo upon PTH stimulation was assessed by averaging
min 2 and 3 while the control (CTR) value reflects min 0 to 1. PTH significantly elevates NPo in TRPV5-WT-expressing cells, whereas it does not
influence NPo in cells expressing TRPV5-W702A. Under control conditions the NPo of TRPV5-W702A is significantly higher than that of
TRPV5-WT. *, P  0.05 versus TRPV5 CTR. (E and F) Averaged recording of TRPV5-WT (E, n 
 5) and TRPV5-W702A (F, n 
 6) over time
using cell-attached patch clamp (holding potential, 80 mV). NPo values were the average of 10-s intervals.
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conformation. The role of calmodulin in single-channel regu-
lation was studied by others previously (10, 29); however, the
structural modulation of a channel by calmodulin is still un-
known (4, 27). Thus, TRPV5 inactivation upon the influx of
Ca2 is mediated by calmodulin to prevent excessive Ca2
influx, which is detrimental for the cell. Ca2-dependent chan-
nel inactivation by calmodulin was also demonstrated for sev-
eral other members of the TRP family (for an overview, see
reference 37) and voltage-gated Ca2 channels (17, 26, 27).
The indispensable role for calmodulin in TRPV5 regulation
also becomes apparent by studying the alignment of the
TRPV5/TRPV6 C termini of different mammalian, reptile, and
fish species. The critical calmodulin-interacting residues W702
and R706 appear to be fully conserved (see Fig. S1 in the
supplemental material).
Recently, PTH-mediated PKA activation was shown to in-
duce TRPV5 stimulation via phosphorylation of the channel at
residue T709, ultimately resulting in an elevation of the chan-
nel-open probability (5). As the T709 residue is located within
the novel calmodulin binding site identified in this study, the
role of T709 phosphorylation in calmodulin binding was stud-
ied using the constitutively active T709D mutant. This T709D
mutant displayed a decrease in calmodulin binding compared
to level of the WT channel or the constitutively inactive T709A
mutant. Then, using living cells, the interplay between T709
phosphorylation and calmodulin binding in the regulation of
TRPV5 function was examined. When PTH-induced phos-
phorylation of T709 releases calmodulin from the TRPV5 C
terminus and thereby increases TRPV5-mediated Ca2 influx,
a TRPV5 mutant with a disrupted calmodulin binding site
should not respond to PTH stimulation. To test this hypothesis
we stimulated TRPV5-W702A with PTH as this mutant does
not interact with calmodulin and still harbors an intact PKA
phosphorylation site around T709. The R706E mutant was not
used as the R706E mutation might affect phosphorylation of
T709 according to the prediction server NetPhosk (www.cbs
.dtu.dk/services). TRPV5-W702A did not respond to PTH
stimulation, as assessed by fura-2 and cell-attached patch
clamp analysis, indicating that the PTH-mediated reduction of
calmodulin binding is essential for TRPV5 activation. These
results demonstrate that PKA-mediated phosphorylation of
T709 diminishes calmodulin binding to the TRPV5 C terminus
and, thereby, increases the activity of the channel. Moreover,
PTH stimulation did not enhance the TRPV5 activity to a
similar extent as introduction of the W702A mutation. This is
in agreement with the more severe reduction in calmodulin
binding of the W702A mutation in comparison to the T709D
mutation.
The counteraction of channel phosphorylation on calmodu-
lin binding is in line with in vitro studies of other ion channels
(11, 19, 21, 28, 35). For the close homologue TRPV6, fluores-
cence resonance energy transfer experiments revealed a Ca2-
dependent and dynamic interaction of calmodulin with the last
part of the TRPV6 C terminus (8). Another study showed that
phosphorylation of a PKC consensus site located within a C-
terminal calmodulin binding domain in hTRPV6 diminished
calmodulin binding to this domain. This, however, was dem-
onstrated only in vitro and does not apply to rabbit or mouse
TRPV6 (21). In the present study, we implemented a physio-
logical stimulus on living cells and thereby established an in-
terplay between PTH-mediated phosphorylation at the fully
conserved residue T709 and calmodulin binding, demon-
strating an essential role for calmodulin in TRPV5 stimula-
tion by PTH.
PTH is released from the parathyroid gland upon low blood
Ca2 levels and acts on the distal part of the nephron to
stimulate active Ca2 reabsorption in order to restore Ca2
homeostasis. Here, we demonstrated that PTH induced PKA-
mediated phosphorylation of residue T709 of the TRPV5
channel, thereby diminishing the binding of calmodulin to the
channel C terminus. Calmodulin release from the C terminus
increased the channel-open probability, eventually stimulating
TRPV5-mediated Ca2 influx (Fig. 8).
FIG. 8. Model illustrating TRPV5 stimulation by parathyroid hormone. Panel 1 illustrates TRPV5 regulation under basal conditions. Panel 2
displays TRPV5 regulation at low extracellular Ca2 levels. PTH release in blood stimulates the PTH receptor, triggering a cAMP-PKA pathway.
This results in the phosphorylation of the TRPV5 C terminus at residue T709. Phosphorylation of T709 diminishes calmodulin (CaM) binding at
the last part of the C terminus, increasing channel-open probability and inducing an enlarged TRPV5-mediated Ca2 influx into the cell. Panel
3 demonstrates the situation in which Ca2 homeostasis is reached, and the increased intracellular Ca2 levels inactivate TRPV5 activity, again
via the binding of calmodulin. AC, adenylyl cyclase.
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